Ravi Salgia to Endothelin Receptor Antagonists
This is a "connection" page, showing publications Ravi Salgia has written about Endothelin Receptor Antagonists.
Connection Strength
0.217
-
Endothelin-axis antagonism enhances tumor perfusion in pancreatic cancer. Cancer Lett. 2022 09 28; 544:215801.
Score: 0.217
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.